HSDT (heliusmedical.com) יחס שווי שוק לשווי בספרים

Helius Medical (HSDT) is developing neurostimulation technologies, however, slow recognition by insurance companies is limiting PoNS sales, which keeps the operating leverage at 0.77. The business relies on strict medical oversight when transporting equipment to therapy centers. This daily price action is presented below, while the company is reducing capital expenditures by outsourcing device assembly to third-party contractors.

This indicator compares the current market value of Helius Medical (HSDT) to its net assets, determining the premium or discount to capital. By analyzing the change in the market value to book capitalization ratio, an investor assesses the real value of the business relative to accounting data. For Helius Medical, this balance reflects market confidence in the expansion of insurance coverage for neurostimulation systems. The stability of the line confirms the company's fundamental resilience, while the absence of sharp spikes eliminates the risk of hidden asset impairment.